600 patients66,869 observations120 daysLIVE

Patient P-01373

Synthetic patientNBL-101 · Day 92 · 25–34 · M · baseline S12Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S12
  2. Day 82 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 82 GI-04 recommendedGI Support Protocol GI-04
  4. Day 83 Patient declinedNot now

What changed?

Trajectory began diverging from predicted response on Day 82.

Primary contributors, last 14 days
  • GI instability+43
  • Inflammatory activity+41
  • Toxicity+32
  • Nutritional resilience-23
  • Treatment adherence-8

What helped?

  • GI Support Protocol GI-04Day 82
    Declined by patient
LIFE OS recommendation
GI Support Protocol GI-04
65%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 86% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
71.3/100
worsening · +21.5 vs previous 14 d
Toxicity
Blood
49.9/100
worsening · +15.2 vs previous 14 d
Sleep quality
Wearable
19.1/100
worsening · -9.2 vs previous 14 d
Energy level
Daily log
2.4/10
worsening · -1.7 vs previous 14 d
Stress level
Daily log
6.7/10
worsening · +1.3 vs previous 14 d
Steps
Wearable
300
worsening · -1,076 vs previous 14 d
Adherence
Companion
80.9 %
stable · +1.5 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 37 from the failing basin, 72 from restoration.

Would help
  • GI-04 GI Support Protocol
    75% improved among 120 similar · onset 8 d · confidence 62%
  • ME-01 Monitoring Escalation
    100% improved among 65 similar · onset 3 d · confidence 72%
  • NP-02 Dietary Support Protocol
    67% improved among 58 similar · onset 10 d · confidence 72%
Would not help
  • Keep fat low
    GI +4.7 next day on high-intake days · n 25
  • Keep alcohol low
    GI +4.7 next day on high-intake days · n 21
  • Keep simple carbs low
    GI +3.1 next day on high-intake days · n 22
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +4.7detractor · 95%
  • Alcohol
    +4.7detractor · 95%
  • Simple carbohydrates
    +3.1detractor · 68%
  • Spicy / capsaicin
    -2.7no signal · 42%
  • Histamine load
    +1.6no signal · 33%
  • Insoluble fibre
    -1.4no signal · 26%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling 70
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 67
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 71 and rising
    • WearableSleep 5.7 h, below personal baseline
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 37/100
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 40
    • Wearable300 steps/day
    • WearableShort sleep window
  • Drug metabolism and exposure 20
    • BloodToxicity index 50
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Rapid metabolizer
    Expected exposure
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2.1 · butyrate capacity 37/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
47 ms
Sleep
6.1 h
Steps
2,024
Resting HR
62 bpm
Daily log: GI score 71, nutritional resilience 32, adherence 81.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • A 15-minute walk after lunch
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0138837%S17CR-01improved59
P-0137136%S06CR-01improved63
P-0132134%S12GI-04improved53
P-0169633%S20CR-01improved59
P-0169933%S04GI-04improved69
P-0183531%S17CR-01improved56
P-0144230%S13CR-01improved61
P-0161429%S14GI-04improved53
P-0132528%S16GI-04improved54
P-0133928%S14GI-04improved54
P-0139328%S14GI-04improved53
P-0151128%S14GI-04improved65